Carboxamines, such as N-Benzyl-4,6-difluoro-1H-indole-2-carboxamide, act as selective PLA2G10 inhibitors [124], and some related compounds have been proven to demonstrate anti-cancer activity, especially in pediatric brain cancer cell lines [109]. The gene discussed is PLA2G10; the disease is cancer.